A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
Enrolling by invitation · NCT06709040 · Registry updated 2026-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters | Bone Diseases, Developmental, Bone Diseases, Endocrine, Dwarfism, Nutritional and Metabolic Diseases, bone disorder, brain disorder, central nervous system disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypopituitarism, hypothalamic disorder, metabolic disease, musculoskeletal system disorder, neoplasm, nervous system disorder, pituitary dwarfism, pituitary gland disorder, type 2 diabetes mellitus | Enrolling by invitation | Not stated | 2026-04-06 | NCT06709040 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novo Nordisk A/S | 181 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Glasgow | Glasgow | United Kingdom | 1 |